Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 876.04M | 1.20B | 1.19B | 888.87M | 505.99M |
Gross Profit | 232.66M | 321.10M | 243.53M | 135.01M | 71.06M |
EBITDA | 35.85M | 356.41M | 85.26M | 5.45M | -49.05M |
Net Income | 3.24M | 297.32M | 43.75M | -18.82M | -61.13M |
Balance Sheet | |||||
Total Assets | 1.01B | 988.95M | 1.01B | 881.46M | 619.91M |
Cash, Cash Equivalents and Short-Term Investments | 34.02M | 39.10M | 74.60M | 71.63M | 119.34M |
Total Debt | 330.98M | 206.16M | 341.60M | 239.08M | 198.32M |
Total Liabilities | 516.61M | 445.40M | 718.96M | 620.20M | 329.47M |
Stockholders Equity | 478.85M | 536.23M | 293.64M | 257.92M | 288.16M |
Cash Flow | |||||
Free Cash Flow | -78.94M | 7.97M | -64.48M | -50.11M | -119.41M |
Operating Cash Flow | -76.62M | 11.86M | -63.03M | -42.20M | -107.97M |
Investing Cash Flow | 48.55M | 45.70M | -16.61M | -26.25M | -74.95M |
Financing Cash Flow | 25.62M | -92.36M | 86.11M | 20.35M | 251.96M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$320.13M | 4.56 | 12.35% | 6.94% | 11.56% | 21.20% | |
71 Outperform | HK$333.57M | 7.03 | 6.61% | 5.76% | -3.59% | 4.81% | |
61 Neutral | HK$228.00M | 24.57 | 2.03% | ― | -39.05% | -80.60% | |
60 Neutral | HK$15.27B | 5.80 | -7.43% | 4.22% | 11.60% | -21.06% | |
59 Neutral | HK$390.48M | 7.53 | 8.82% | 2.76% | -10.82% | -44.11% | |
47 Neutral | HK$326.31M | 86.90 | 0.64% | 19.18% | -26.91% | -98.72% | |
47 Neutral | HK$263.25M | 0.29 | 1417.08% | ― | -20.01% | ― |
Tycoon Group Holdings Limited has announced amendments to the terms of reference for its Nomination Committee, effective from July 1, 2025. These changes emphasize diversity and independence within the committee, requiring a minimum of three members, the majority being independent non-executive directors, and at least one member of a different gender. This move is likely to enhance the company’s governance practices and strengthen its commitment to diversity and independent oversight, potentially impacting its reputation positively among stakeholders.
Tycoon Group Holdings Limited has announced changes to its board of directors, effective from July 1, 2025. The company, which is incorporated in the Cayman Islands, has appointed Mr. Wong Ka Chun Michael as the Chairman and Chief Executive Officer. The board will also include a mix of non-executive and independent non-executive directors, each serving on various committees such as Audit, Remuneration, Nomination, and Corporate Governance. This restructuring is likely to impact the company’s governance and strategic direction, potentially influencing its market positioning and stakeholder relations.
Tycoon Group Holdings Limited has announced changes in its board of directors, with the resignation of Mr. Hu Yang as a non-executive director due to work adjustments, effective July 1, 2025. The company has appointed Mr. Ng Kwan Ho and Mr. Cao Ran as non-executive directors, also effective from July 1, 2025. Mr. Ng brings extensive experience in marketing and brand management, having held senior positions in various companies, including JBM (Healthcare) Limited and Amway Hong Kong Limited. These changes are expected to bring new perspectives and expertise to the company’s board, potentially impacting its strategic direction and market positioning.
Tycoon Group Holdings Limited announced that all resolutions proposed at its Annual General Meeting on 30 May 2025 were approved by shareholders. The resolutions included the re-election of directors, adoption of new articles of association, and granting of mandates for share repurchase and issuance. This unanimous approval reflects strong shareholder support and positions the company for strategic flexibility in its operations.
Tycoon Group Holdings Limited has entered into supplemental agreements with Europharm and Jacobson Medical to establish a fixed period ending on 31 March 2028 for their distribution agreements. The proposed annual caps for the purchase of products under these agreements have been set, and the transactions are subject to annual review and disclosure requirements under the Listing Rules, but are exempt from certain approval requirements.
Tycoon Group Holdings Limited has completed the issuance of 94,000,000 shares under a general mandate at an issue price of HK$0.5 per share, with the completion taking place on May 22, 2025. This transaction has resulted in the Subscriber, an indirect wholly-owned subsidiary of Jacobson Pharma, becoming a substantial shareholder with a 16.84% stake in the company, thus establishing new connected person relationships and ongoing connected transactions under the Listing Rules.
Tycoon Group Holdings Limited announced a proposed issue of shares under a general mandate, aiming to raise approximately HK$46.7 million. The proceeds are intended for general working capital, including inventory purchases, logistics, marketing, and other operational needs. The subscription price is set at a premium, reflecting confidence in the company despite recent financial challenges. This move is expected to strengthen the company’s financial position, reduce debt-to-equity ratio, and enhance stakeholder confidence, especially following a recent forced-sale event.
Tycoon Group Holdings Limited has announced supplemental information regarding its continuing connected transactions, focusing on the 2025 Master Sale and Purchase Agreement with Talent Smart Group. The company anticipates increased purchases of Talent Smart Products due to the launch of 24 new products and the expansion of its distribution channels in Southeast Asia and e-commerce platforms in the PRC. The reinstatement of Combo Win Asia Limited as a wholly-owned subsidiary is expected to enhance the company’s e-commerce capabilities, potentially boosting sales and market reach.
Tycoon Group Holdings Limited has entered into a Subscription Agreement to issue 94,000,000 shares at HK$0.5 each, representing approximately 11.75% of its current issued share capital. The proceeds, estimated at HK$46.7 million after expenses, will be used to invest in core business growth and improve supply chain and logistics operations, positioning the company for expansion.
Tycoon Group Holdings Limited announced unusual price and trading volume movements in its shares, leading to a forced sale of 129,060,000 shares held by Tycoon Empire Investment Limited, controlled by Mr. Wong Ka Chun Michael. Despite this, the company confirmed that its business operations remain normal, with no material changes to its financial position. Trading was temporarily halted but is set to resume, with stakeholders advised to exercise caution.
Tycoon Group Holdings Limited has announced a trading halt on the Hong Kong Stock Exchange, effective from 11:30 a.m. on April 16, 2025, pending the release of an announcement regarding certain inside information. This move indicates a significant development within the company that could impact its operations and market perception, leaving stakeholders and investors anticipating further details.
Tycoon Group Holdings Limited has announced its upcoming annual general meeting scheduled for May 30, 2025, in Hong Kong. Key agenda items include the adoption of the company’s 2024 financial statements, re-election of non-executive directors, re-appointment of PricewaterhouseCoopers as auditors, and resolutions concerning share repurchase and issuance. These decisions are crucial for the company’s governance and strategic direction, impacting shareholders and market positioning.